A 4 Week Study of Elidel for the Treatment of Seborrheic Dermatitis
| Status: | Completed |
|---|---|
| Conditions: | Dermatology, Dermatology |
| Therapuetic Areas: | Dermatology / Plastic Surgery |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 10/14/2017 |
| Start Date: | January 2007 |
| End Date: | January 2009 |
A 4 Week Randomized Double-Blind Parallel Group Active Comparator Controlled Study of Elidel for the Treatment of Seborrheic Dermatitis
This is an exploratory study to determine effectiveness of Elidel for the treatment of
seborrheic dermatitis
seborrheic dermatitis
This is a 4 week study for patients 18 and olderto compare the efficacy and safety of
pimecrolimus cream 1% twice daily and ketaconazole cream 2 % twice daily for the treatment of
seborrheic dermatitis.
pimecrolimus cream 1% twice daily and ketaconazole cream 2 % twice daily for the treatment of
seborrheic dermatitis.
Inclusion Criteria:
- Must be 18 or older and sign written informed consent.
- Must be wiling and able to comply with protocol.
- Must have active seborrheic dermatitis of the face.
Exclusion Criteria:
- No history of overt bacterial, viral or fungal infection of the head/neck.
- No history or presence of compromising dermatosis elsewhere on the skin
- No Parkinson's disease, HIV, infections or disorders of the central nervous system
- No actinically damaged skin
We found this trial at
1
site
Click here to add this to my saved trials
